Iktos is a company developing an artificial intelligence technology for ligand-based drug design, focusing on MPO (multi-parametric optimization). Its proprietary algorithm is based on deep learning models, called generative models, enabling to design new, druggable, and synthesizable molecules under the constraint of a given blueprint. The company serves pharmaceutical and agrochemical companies.